Turn Therapeutics TTRX
NASDAQ TTRX
$9.74 -0.05 (-0.46%)
As of: Nov 10, 2026 · 12:56 PM EST

Turn Therapeutics (TTRX) Assets (2024 - 2026)

Updated

Turn Therapeutics' Assets was $16.96 million in Q2 2026, down 9.0% from the prior quarter.

Analysis

Turn Therapeutics (TTRX) Assets (2024 - 2026) Analysis & Trends

At the end of FY2025, Assets at Turn Therapeutics came in at $12.16 million, up 493.6% from FY2024.

  • In earlier years, Assets was $2.05 million in FY2024.
  • Quarterly Assets has moved between $2.05 million (Q4 2024) and $18.64 million (Q1 2026) over five years.
  • Per Business Quant data, TTRX's Assets in the three quarters before Q2 2026 was $18.64 million (Q1 2026), $12.16 million (Q4 2025) and $4.3 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 197.43 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 147.68 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 115.83 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 51.41 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 205.00 Bn
10 Turn Therapeutics 300.41 Mn 273.52 Mn - 16.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 16.96 Mn
Mar 31, 2026 18.64 Mn
Dec 31, 2025 12.16 Mn
Sep 30, 2025 4.30 Mn
Dec 31, 2024 2.05 Mn
API Access

Turn Therapeutics Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=assets&ticker=TTRX&period=max&api_key=YOUR_API_KEY